GQ-1003

N/A

Report date: 2024/04/23 13:35:00

Base Information

Drug NameGQ-1003
Drug Alias NameGQ-1003GQ1003
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)
Mechanisms of ActionAnti-Trop-2
TargetsTumor-associated calcium signal transducer 2
Therapy Area/IndicationsSolid tumoursCarcinoma, Non-Small-Cell LungTriple Negative Breast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesGeneQuantum Healthcare (Suzhou) Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesGeneQuantum Healthcare (Suzhou) Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumoursCarcinoma, Non-Small-Cell LungTriple Negative Breast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A